certificate of analysis raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-06-14. Anything still debated is marked as such rather than presented as settled.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
| Property | Value | Notes |
|---|---|---|
| Synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
| Common form | Crystalline powder | Supplied in milligram to gram quantities |
| Long-term storage | -20 °C, desiccated, protected from light | Reduces degradation |
| Detection technique | LC-MS/MS | Common in anti-doping and research analysis |
| Regulatory status | Prohibited in sport by WADA | Not approved for human therapeutic use |
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
== Structure == TN-X possesses a modular structure composed, from the N- to the C-terminal part by a Tenascin assembly domain (TAD), a series of 18.5 repeats of epidermal growth factor (EGF)-like motif, a high number of Fibronectin type III (FNIII) module, and a fibrinogen (FBG)-like globular domain.
An antihemorrhagic (British English: antihaemorrhagic) agent is a substance that promotes hemostasis (a process which stops bleeding). It may also be known as a hemostatic (also spelled haemostatic) agent. Antihemorrhagic agents used in medicine have various mechanisms of action:
=== Differential diagnosis === Several disorders share some characteristics with EDS. For example, in cutis laxa, the skin is loose, hanging, and wrinkled. In EDS, the skin can be pulled away from the body, but is elastic and returns to normal when let go. In Marfan syndrome, the joints are very mobile, and similar cardiovascular complications occur. People with a "marfanoid" appearance are often tall and thin with long arms and legs and "spidery" fingers, while EDS phenotypes vary considerably. Certain subtypes of EDS may involve short stature, large eyes, and the appearance of a small mouth and chin, due to a small palate. The palate can have a high arch, causing dental crowding. Blood vessels can sometimes be easily seen through translucent skin, especially on the chest. The genetic connective tissue disorder Loeys–Dietz syndrome also has symptoms that overlap with EDS. In the past, Menkes disease, a copper metabolism disorder, was thought to be a form of EDS. People are commonly misdiagnosed with fibromyalgia, bleeding disorders, or other disorders that can mimic EDS symptoms. Because of these similar disorders and complications that can arise from an unmonitored case of EDS, a correct diagnosis is important. Pseudoxanthoma elasticum is worth consideration in diagnosis.
In July 2020, the studio announced it was working on a new game. The Chinese Room revealed their new game, Still Wakes the Deep, at the Xbox Games Showcase 2023. On 17 July 2023, following the announcement of their new game, co-founder and creative director Dan Pinchbeck announced his departure from the studio after 15 years. At their PAX West panel, Paradox Interactive revealed that the Chinese Room had taken over development duties on Vampire: The Masquerade – Bloodlines 2 from Hardsuit Labs, who were fired from the project in 2021.
to improve glycemic control when metformin with or without sulphonylurea (SU) and either saxagliptin or dapagliflozin does not provide adequate glycemic control. when already being treated with metformin and saxagliptin and dapagliflozin.
Sources: en.wikipedia.org
=== Religion === In general, the Houthi movement has centered its belief system on the Zaydi branch of Islam, a sect almost exclusively present in Yemen. Zaydis form about 34% of the population, with Sunnis comprising about 65%. Zaydi-led governments ruled Yemen for a thousand years up until 1962. The Houthi movement has often advocated for Zaydi revivalism in Yemen since its foundation. Although the group has framed its struggle in religious terms and put great importance on its Zaydi roots, the Houthis are not an exclusively Zaydi group. They have rejected their portrayal by others as a faction that is purportedly only interested in Zaydi-related issues. They have not publicly advocated for the restoration of the old Zaydi imamate, although analysts have argued that they might plan to restore it in the future. Most Yemenis have a low opinion of the old imamate, and Hussein al-Houthi also did not advocate the imamate's restoration. Instead, he proposed a "Guiding Eminence" (alam al-huda): an individual descended from the Prophet who would act as a "universal leader for the world". However, he never defined this position's prerogatives or how they should be appointed.
== Further reading == Ye, Yanqi; Yu, Jicheng; Gu, Zhen (2015). "Versatile Protein Nanogels Prepared by In Situ Polymerization". Macromolecular Chemistry and Physics. 217 (3): 333–343. doi:10.1002/macp.201500296. Yan, Ming; Ge, Jun; Liu, Zheng; Ouyang, Pingkai (2006). "Encapsulation of Single Enzyme in Nanogel with Enhanced Biocatalytic Activity and Stability". Journal of the American Chemical Society. 128 (34): 11008–9. Bibcode:2006JAChS.12811008Y. doi:10.1021/ja064126t. PMID 16925402. Reese, Chad E.; Mikhonin, Alexander V.; Kamenjicki, Marta; Tikhonov, Alexander; Asher, Sanford A. (2004). "Nanogel Nanosecond Photonic Crystal Optical Switching". Journal of the American Chemical Society. 126 (5): 1493–6. Bibcode:2004JAChS.126.1493R. doi:10.1021/ja037118a. PMID 14759207. Lee, Eun Seong; Kim, Dongin; Youn, Yu Seok; Oh, Kyung Taek; Bae, You Han (2008). "A Virus-Mimetic Nanogel Vehicle". Angewandte Chemie International Edition. 47 (13): 2418–21. Bibcode:2008ACIE...47.2418L. doi:10.1002/anie.200704121. PMC 3118583. PMID 18236507. Hasegawa, Urara; Nomura, Shin-Ichiro M.; Kaul, Sunil C.; Hirano, Takashi; Akiyoshi, Kazunari (2005). "Nanogel-quantum dot hybrid nanoparticles for live cell imaging". Biochemical and Biophysical Research Communications. 331 (4): 917–21. Bibcode:2005BBRC..331..917H. doi:10.1016/j.bbrc.2005.03.228. PMID 15882965. Du, Jin-Zhi; Sun, Tian-Meng; Song, Wen-Jing; Wu, Juan; Wang, Jun (2010). "A Tumor-Acidity-Activated Charge-Conversional Nanogel as an Intelligent Vehicle for Promoted Tumoral-Cell Uptake and Drug Delivery".
==== Protein-based adhesives ==== Protein-based adhesives are less prevalent and typically used to consolidate painted textiles or multi-media objects, of which fabric is one component. They include isinglass, gelatin, and animal glues.
Press release describing discovery of Osedax BBC website – link to story about discovery of Osedax worms in the North Sea A Motley Collection of Boneworms – Monterey Bay Aquarium Research Institute Discovered in the deep: the worm that eats bones – The Guardian
Sources: en.wikipedia.org
An alternative model, proposed by politicians in Oldenburg and Brunswick, envisaged the foundation of the independent state of "Weser-Ems", that would be formed from the state of Oldenburg, the Hanseatic City of Bremen and the administrative regions of Aurich and Osnabrück. Several representatives of the state of Oldenburg even demanded the inclusion of the Hanoverian districts of Diepholz, Syke, Osterholz-Scharmbeck and Wesermünde in the proposed state of "Weser-Ems". Likewise an enlarged State of Brunswick was proposed in the southeast to include the Regierungsbezirk of Hildesheim and the district of Gifhorn. Had this plan come to fruition, the territory of the present Lower Saxony would have consisted of three states of roughly equal size. The district council of Vechta protested on 12 June 1946 against being incorporated into the metropolitan area of Hanover (Großraum Hannover). If the State of Oldenburg was to be dissolved, Vechta District would much rather be included in the Westphalian region. Particularly in the districts where there was a political Catholicism the notion was widespread, that Oldenburg Münsterland and the Regierungsbezirk of Osnabrück should be part of a newly formed State of Westphalia. Since the foundation of the states of North Rhine-Westphalia and Hanover on 23 August 1946 the northern and eastern border of North Rhine-Westphalia has largely been identical with that of the Prussian Province of Westphalia. Only the Free State of Lippe was not incorporated into North Rhine-Westphalia until January 1947.
In collaboration with the Academic Medical Center in Amsterdam, Inreda Diabetic B.V. has developed a closed loop system with insulin and glucagon. The initiator, Robin Koops, started to develop the device in 2004 and ran the first tests on himself. In October 2016 Inreda Diabetic B.V. got the ISO 13485 license, a first requirement to produce its artificial pancreas. The product itself is called Inreda AP, and soon made some highly successful trials. After clinical trials, it received the CE marking, noting that it complies with European regulation, in February 2020. In October 2020 the health insurance company Menzis and Inreda Diabetic then started a pilot with 100 patients insured by Menzis. These are all patients that face very serious trouble in regulating their blood glucose levels. They now use the Inreda AP instead of the traditional treatment. Another large scale trial with the Inreda AP was set up in July 2021, and should determine whether Dutch health insurance should cover the device for all their insured. A smaller improved version of the Inreda AP is scheduled for release in 2023.
Nanospray desorption electrospray ionization (nano-DESI) is an ambient pressure ionization technique used in mass spectrometry (MS) for chemical analysis of organic molecules. In this technique, analytes are desorbed into a liquid bridge formed between two capillaries and the sampling surface. Unlike desorption electrospray ionization (DESI), from which nano-DESI is derived, nano-DESI makes use of a secondary capillary, which improves the sampling efficiency.
Sources: en.wikipedia.org
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.
Research-grade purity indicates a supplier's measured percentage of the intended compound. It does not guarantee safety, sterility, or suitability for human consumption. Buyers should request a certificate of analysis with chromatograms and test methods.
Sports regulators prohibit SR9009 because it is a non-approved substance with potential performance-altering effects. Its presence can be detected in anti-doping testing. Athletes are responsible for substances found in their samples.
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.